Literature DB >> 34289987

TGFβ Signaling Activated by Cancer-Associated Fibroblasts Determines the Histological Signature of Lung Adenocarcinoma.

Ryo Sato1,2, Kosuke Imamura2, Takashi Semba1,3, Yusuke Tomita2, Sho Saeki2, Koei Ikeda3, Yoshihiro Komohara4, Makoto Suzuki3, Takuro Sakagami2, Hideyuki Saya1, Yoshimi Arima5.   

Abstract

Invasive lung adenocarcinoma (LADC) can be classified histologically as lepidic, acinar, papillary, micropapillary, or solid. Most LADC tumors manifest several of these histological subtypes, with heterogeneity being related to therapeutic resistance. We report here that in immunodeficient mice, human LADC cells form tumors with distinct histological features, MUC5AC-expressing solid-type or cytokeratin 7 (CK7)-expressing acinar-type tumors, depending on the site of development, and that a solid-to-acinar transition (SAT) could be induced by the tumor microenvironment. The TGFβ-Smad signaling pathway was activated in both tumor and stromal cells of acinar-type tumors. Immortalized cancer-associated fibroblasts (CAF) derived from acinar-type tumors induced SAT in 3D cocultures with LADC cells. Exogenous TGFβ1 or overexpression of an active form of TGFβ1 increased CK7 expression and reduced MUC5AC expression in LADC cells, and knockdown of Tgfb1 mRNA in CAFs attenuated SAT induction. RNA-sequencing analysis suggested that angiogenesis and neutrophil recruitment are associated with SAT in vivo. Our data indicate that CAF-mediated paracrine TGFβ signaling induces remodeling of tumor tissue and determines the histological pattern of LADC, thereby contributing to tumor heterogeneity. SIGNIFICANCE: CAFs secrete TGFβ to induce a solid-to-acinar transition in lung cancer cells, demonstrating how the tumor microenvironment influences histological patterns and tumor heterogeneity in lung adenocarcinoma. ©2021 The Authors; Published by the American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34289987     DOI: 10.1158/0008-5472.CAN-20-3941

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  5 in total

Review 1.  Clinical Application Perspectives of Lung Cancers 3D Tumor Microenvironment Models for In Vitro Cultures.

Authors:  Irena Wieleba; Kamila Wojas-Krawczyk; Paweł Krawczyk; Janusz Milanowski
Journal:  Int J Mol Sci       Date:  2022-02-18       Impact factor: 5.923

Review 2.  The Good, the Bad, and the Ugly: Neutrophils, Angiogenesis, and Cancer.

Authors:  Irem Ozel; Inga Duerig; Maksim Domnich; Stephan Lang; Ekaterina Pylaeva; Jadwiga Jablonska
Journal:  Cancers (Basel)       Date:  2022-01-21       Impact factor: 6.639

Review 3.  Integrin α11β1 in tumor fibrosis: more than just another cancer-associated fibroblast biomarker?

Authors:  Cédric Zeltz; Roya Navab; Ritva Heljasvaara; Marion Kusche-Gullberg; Ning Lu; Ming-Sound Tsao; Donald Gullberg
Journal:  J Cell Commun Signal       Date:  2022-04-04       Impact factor: 5.782

Review 4.  Chimeric antigen receptor T-cell therapy: challenges and opportunities in lung cancer.

Authors:  Caili Xu; Dianwen Ju; Xuyao Zhang
Journal:  Antib Ther       Date:  2022-02-23

5.  Clinicopathological and Prognostic Significance of Stromal Patterns in Oral Squamous Cell Carcinoma.

Authors:  Yusuke Amano; Atsushi Kihara; Masayo Hasegawa; Tamaki Miura; Daisuke Matsubara; Noriyoshi Fukushima; Hiroshi Nishino; Yoshiyuki Mori; Toshiro Niki
Journal:  Front Med (Lausanne)       Date:  2022-04-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.